Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial.
Lend K, van Vollenhoven RF, Lampa J, Lund Hetland M, Haavardsholm EA, Nordström D, Nurmohamed M, Gudbjornsson B, Rudin A, Østergaard M, Uhlig T, Grondal G, Hørslev-Petersen K, Heiberg MS, Sokka-Isler T, Koopman FA, Twisk JWR, van der Horst-Bruinsma I. Lend K, et al. Among authors: lund hetland m. Lancet Rheumatol. 2022 Oct;4(10):e688-e698. doi: 10.1016/S2665-9913(22)00186-2. Epub 2022 Aug 23. Lancet Rheumatol. 2022. PMID: 38265967 Clinical Trial.
Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
Ellingsen T, Hansen I, Thorsen J, Kuno Møller B, Tarp U, Jacobsen S, Lund Hetland M, Vestergaard A, Hørslev-Petersen K, Stengaard-Pedersen K. Ellingsen T, et al. Among authors: lund hetland m. Clin Exp Rheumatol. 2012 Jan-Feb;30(1):58-63. Epub 2012 Mar 6. Clin Exp Rheumatol. 2012. PMID: 22273590 Clinical Trial.
Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies.
Curtis JR, Brahe CH, Østergaard M, Lund Hetland M, Hambardzumyan K, Saevarsdottir S, Wang X, Flake Ii DD, Sasso EH, Huizinga TW. Curtis JR, et al. Among authors: lund hetland m. Curr Med Res Opin. 2019 Sep;35(9):1483-1493. doi: 10.1080/03007995.2019.1585064. Epub 2019 Mar 14. Curr Med Res Opin. 2019. PMID: 30777458 Free article.
Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study.
Hendricks O, Andersen TE, Christiansen AA, Primdahl J, Hauge EM, Ellingsen T, Horsted TI, Bachmann AG, Loft AG, Bojesen AB, Østergaard M, Lund Hetland M, Krogh NS, Roessler KK, Petersen KH. Hendricks O, et al. Among authors: lund hetland m. BMJ Open. 2019 Jun 4;9(6):e028197. doi: 10.1136/bmjopen-2018-028197. BMJ Open. 2019. PMID: 31167870 Free PMC article.
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.
Lindström U, Glintborg B, Di Giuseppe D, Nordström D, Aarrestad Provan S, Gudbjornsson B, Askling J, Lund Hetland M, Aaltonen K, Krogh NS, Geirsson AJ, Jacobsson LTH. Lindström U, et al. Among authors: lund hetland m. RMD Open. 2019 Oct 23;5(2):e001079. doi: 10.1136/rmdopen-2019-001079. eCollection 2019. RMD Open. 2019. PMID: 31749988 Free PMC article.
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Lindström U, Glintborg B, Di Giuseppe D, Schjødt Jørgensen T, Gudbjornsson B, Lederballe Grøn K, Aarrestad Provan S, Michelsen B, Lund Hetland M, Wallman JK, Nordström D, Trokovic N, Love TJ, Krogh NS, Askling J, Jacobsson LTH, Kristensen LE. Lindström U, et al. Among authors: lund hetland m. Rheumatology (Oxford). 2021 Aug 2;60(8):3635-3645. doi: 10.1093/rheumatology/keaa825. Rheumatology (Oxford). 2021. PMID: 33367900
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
Aldridge J, Lundell AC, Andersson K, Mark L, Lund Hetland M, Østergaard M, Uhlig T, Schrumpf Heiberg M, Haavardsholm EA, Nurmohamed M, Lampa J, Nordström D, Hørslev-Petersen K, Gudbjornsson B, Gröndal G, van Vollenhoven R, Rudin A. Aldridge J, et al. Among authors: lund hetland m. Clin Exp Rheumatol. 2022 Jul;40(7):1393-1402. doi: 10.55563/clinexprheumatol/idogmj. Epub 2021 Nov 3. Clin Exp Rheumatol. 2022. PMID: 34796837
Occurrence and Prediction of Flare After Tapering of Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis.
Wetterslev M, Georgiadis S, Nysom Christiansen S, Pedersen SJ, Juul Sørensen I, Lund Hetland M, Duer A, Boesen M, Gosvig KK, Møller JM, Bakkegaard M, Heegaard Brahe C, Krogh NS, Jensen B, Madsen OR, Christensen J, Hansen A, Nørregaard J, Røgind H, Østergaard M. Wetterslev M, et al. Among authors: lund hetland m. J Rheumatol. 2023 Oct 15:jrheum.2023-0495. doi: 10.3899/jrheum.2023-0495. Online ahead of print. J Rheumatol. 2023. PMID: 37839816
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.
Liu J, Idborg H, Korotkova M, Lend K, van Vollenhoven R, Lampa J, Rudin A, Nordström D, Gudbjornsson B, Gröndal G, Uhlig T, Hørslev-Petersen K, Lund Hetland M, Østergaard M, Nurmohamed M, Jakobsson PJ. Liu J, et al. Among authors: lund hetland m. Arthritis Res Ther. 2024 Mar 5;26(1):61. doi: 10.1186/s13075-024-03295-9. Arthritis Res Ther. 2024. PMID: 38444034 Free PMC article. Clinical Trial.
16 results